Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

In vivo administration of interferon alpha and interleukin 2 induces proliferation of lymphoid cells in the organs of mice

Journal Article · · Cancer Research; (USA)
OSTI ID:6528824

We have previously shown that interleukin 2 (IL-2) synergizes with interferon alpha (IFN-alpha) in mediating the regression of established pulmonary and hepatic metastases and the reduction of intradermal tumor in various murine tumor models. To understand the mechanism of synergy, we have examined lymphoid cell proliferation in various organs of mice in response to IL-2 and IFN-alpha administration. We have utilized a technique for labeling newly synthesized DNA in vivo with 5-(125I)iodo-2'-deoxyuridine to examine proliferation of endogenous cells in response to IL-2 and IL-2 plus IFN-alpha. A proliferation index was calculated by dividing cpm in the tissues treated with cytokines by cpm obtained in corresponding tissues of control mice. After 4 days of IL-2 administration, a significant uptake of 5-(125I)iodo-2'-deoxyuridine was observed in the lungs, liver, kidneys, and spleen (proliferation index of 13, 10.3, 3.6, and 3.2, respectively). IFN-alpha alone mediated very little incorporation of radiolabel but when administered in combination with IL-2 a reduction of IL-2-induced proliferation was seen on day 4. For example 19,272 +/- 4,556 cpm (mean +/- SE) were obtained in the liver of IL-2-treated mice, compared to 8,103 +/- 2,111 cpm in livers of IL-2 plus IFN-alpha-treated mice (P less than 0.05). Similar inhibition of IL-2-induced proliferation was observed in the lungs, kidneys, and spleen. In contrast, on days 7 or 8, higher uptake of radiolabel was obtained in IFN-alpha plus IL-2-treated lungs, liver, and kidneys, compared to organs of mice treated with IL-2 alone or IFN-alpha alone. A proliferation index of 30.5, 9.8, and 10 was obtained in the lungs, liver, and kidneys of IL-2- plus IFN-alpha-treated animals, compared to 9.6, 3.6, and 5.5 in the corresponding organs of IL-2-treated mice.

OSTI ID:
6528824
Journal Information:
Cancer Research; (USA), Journal Name: Cancer Research; (USA) Vol. 50:17; ISSN CNREA; ISSN 0008-5472
Country of Publication:
United States
Language:
English

Similar Records

Systemic administration of recombinant interleukin 2 stimulates in vivo lymphoid cell proliferation in tissues
Journal Article · Thu Aug 01 00:00:00 EDT 1985 · J. Immunol.; (United States) · OSTI ID:5218263

Recombinant interleukin 2 stimulates in vivo proliferation of adoptively transferred lymphokine-activated killer (LAK) cells
Journal Article · Thu Oct 31 23:00:00 EST 1985 · J. Immunol.; (United States) · OSTI ID:6235249

Pharmacokinetics, tissue distribution, and cell localization of ( sup 35 S)methionine-labeled recombinant human and murine alpha interferons in mice
Journal Article · Wed Aug 01 00:00:00 EDT 1990 · Cancer Research; (USA) · OSTI ID:6649739